Private Health Management

We’re #hiring a new Associate Clinical Director - Serious & Complex in United States. Apply today or share this post with your network.

Clinical trials are transforming cancer care by improving outcomes and lowering costs. In this episode of the Springbuk podcast, PHM’s Natalya Gertsik, PhD, and Tommy Axford explore how these trials offer significant medical benefits and cost-effective solutions, empowering employers to address the rising cancer-related expenses that affect their healthcare expenditures. For more information, explore our latest whitepaper “The Importance of Clinical Trials in Cancer Care” - https://lnkd.in/gvgUavYm

𝐍𝐞𝐰 𝐋𝐨𝐨𝐤, 𝐒𝐚𝐦𝐞 𝐎𝐮𝐭𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐒𝐞𝐫𝐯𝐢𝐜𝐞 We’re excited to unveil our new look and website experience at Private Health Management (PHM)! For more than 17 years, PHM has been bridging the gaps in our healthcare system, providing high acuity patient guidance for individuals navigating serious and complex conditions. We continue to provide access to the latest science-backed insights, top diagnostics, specialists, and treatments, along with expert guidance to empower informed health decisions. As we approach 2025, you’ll see our new look implemented across all platforms. Explore our updated digital presence at 𝐩𝐫𝐢𝐯𝐚𝐭𝐞𝐡𝐞𝐚𝐥𝐭𝐡.𝐜𝐨𝐦 and discover how we can support or partner with you. #PrivateHealthManagement #ComplexCare #PrecisionMedicine #EmployeeBenefits

A recent international study published in 𝘕𝘢𝘵𝘶𝘳𝘦 offers groundbreaking insights into personalized peptide vaccines for glioblastoma (GBM) treatment, representing the largest real-world study of its kind. Private Health Management’s scientific researcher David D. Parker Jr. contributed to this pivotal work, collaborating with Dr. Saskia Biskup, MD, PhD, and Co-founder of Provenance Precision Medicine Foundation. This study showcases the potential of personalized medicine in tackling one of the most aggressive and deadliest types of brain cancer. The study confirms that producing and applying a tailored vaccine is both feasible and effective within a practical timeframe, paving the way for future clinical trials. Read the full article here: https://lnkd.in/gJZj9ukv #CancerResearch #Glioblastoma #PersonalizedMedicine #PrecisionMedicine #PrivateHealthManagement

We are thrilled to welcome Michelle (Shelley) Kemling as our new Chief People Officer at Private Health Management! Michelle brings a wealth of experience and a passion for cultivating positive workplace cultures through people-first and data-informed strategies. She excels at aligning employee satisfaction with organizational goals, fostering a culture of empowered employees and driving enhanced performance. Known for her authentic and compassionate communication style, Michelle inspires collaboration and motivates teams to excel. She is both strategic and hands-on, committed to creating systems that support PHM’s mission of delivering the best care and outcomes. Please join us in welcoming Michelle to PHM! We are excited about the positive impact she will bring to our team and culture.

Rare diseases like Stiff Person Syndrome (SPS) often go unnoticed, but their impact on those affected is profound. With symptoms that range from debilitating muscle spasms to difficulty walking, SPS is a complex condition that demands specialized care. PHM's Mariangela Nikolakopoulou Okhovat, PhD delves into the complexities of SPS and shares why proper diagnosis may take time. Learn more about SPS and its impact: https://lnkd.in/ddnfTRRP #stiffpersonsyndrome #autoimmune #privatehealthmanagement #caremanagement #seriousandcomplexdiseases

Alzheimer’s affects more than 6 million Americans, making early diagnosis critical yet challenging. A groundbreaking study introduces a non-invasive blood test that could change this. With 91% accuracy, this test significantly outperforms traditional methods, offering a new avenue for early detection and treatment. Alzheimer’s is the leading cause of dementia, and timely diagnosis is crucial. At PHM, our experts stay informed on the latest in Alzheimer’s care. Learn more about this innovative blood test from PHM experts Jimmy W. Ou, Ph.D and Tracy Arsenault: https://lnkd.in/gxzKtaiH #AlzheimersAwareness #PrecisionMedicine #InnovativeCare #privatehealthmanagement

The FDA has approved the first blood test for colorectal cancer screening. Guardant Health’s Shield™ is a non-invasive primary screening blood test option that could make screening more accessible and catch cancer early when it's most treatable. Colorectal cancer is a leading cause of cancer deaths in the U.S., with the American Cancer Society estimating 106,590 new cases of colon cancer and 46,220 new cases of rectal cancer in 2024. Choosing the right screening option involves considering factors like family history, lifestyle, and age. At PHM, our experts stay up to date on the latest developments in cancer screening and help guide our clients in choosing the screening methods that are right for them. Learn more about Guardant Health's Shield™ test from our PHM experts Lee D. Gibbs, Ph.D. and Tracy Arsenault: https://lnkd.in/gwpgtAhw #colorectalcancer #cancerscreening #employeehealth #cancercare #privatehealthmanagement 

We are excited to share the news of our latest collaboration with Innovative Captive Strategies (“ICS”), a leading provider of captive insurance solutions, to deliver comprehensive care support to ICS’s clients and their plan members.   “This partnership underscores our commitment to helping our clients effectively manage risk and support their workforce during a health crisis,” said Matthew Durham, AVP, ICS. “It represents a significant step in ICS’s strategy to offer world-class services. We encourage our clients to leverage PHM’s clinical expertise to ensure their members receive the best possible care, improving health outcomes, and reducing costs.”    As a leading complex care management company, Private Health Management specializes in guiding individuals through serious and complex medical conditions to achieve the best care and outcomes. Businesses prioritizing employee health trust PHM to achieve the best of what's possible in medicine.   Read the full press release: https://lnkd.in/gdVQwX7f   #privatehealthmanagement #innovativecaptivestrategies #employeehealth #employeebenefits

Today, PHM has released “The Importance of Clinical Trials in Cancer Care” whitepaper for benefit leaders. This report highlights the critical role of clinical trials in advancing cancer treatment, improving patient outcomes, and lowering costs for employers. Clinical trials are crucial for testing the safety and efficacy of new medical treatments and interventions. However, access to these trials has often been hindered by the clinical and scientific complexity of identifying and prioritizing appropriate trials. PHM is proud of its ability to bridge the gap between groundbreaking medical research and the patients who may benefit from it. Learn how integrating clinical trials into health plans can benefit both patients and employers: https://lnkd.in/gvgUavYm Read the press release: https://lnkd.in/gaSvV2_N Our thanks to PHM’s team of researchers and clinicians for their contribution to this whitepaper - Eva J. Gordon, PhD, Natalya Gertsik, PhD, Tommy Axford, Lee D. Gibbs, Ph.D., Ross Keller, PhD, Erika Sharpe, Amber McDonald, Julie Nowicki, and Zach Doran #clinicalresearch #clinicaltrials #cancercare #employerbenefits #employerhealthplans